Home › Funds › Spruce Street Capital LP › ANTX
Spruce Street Capital LP position in ANTX
AN2 THERAPEUTICS INC · Health Care
Spruce Street Capital LP reported holding 1,752,011 shares of ANTX (AN2 THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$9.3M, representing 1.48% of its reported portfolio and ranking #21 among its reported holdings. Spruce Street Capital LP has disclosed ANTX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Spruce Street Capital LP's ANTX position evolved
Spruce Street Capital LP first disclosed a stake in ANTX in Q1 2026 at 1,661,073 shares (US$5.6M). The position peaked in Q3 2026 at 1,752,011 shares, worth US$9.3M. Across 3 filings, Spruce Street Capital LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,752,011 shares valued at US$9.3M — an increase of 90,938 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 1.66M | $5.58M | New |
| Q2 2026 | 1.66M | $8.04M | Hold |
| Q3 2026 | 1.75M | $9.32M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ANTX and 13F data
ANTX (AN2 THERAPEUTICS INC) is a Health Care company. 45 other funds we track also report a position in ANTX — the largest reported positions include Vivo Capital, LLC (US$16.8M), Commodore Capital LP (US$14.2M), Almitas Capital LLC (US$7.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANTX
- Vivo Capital, LLC 3.15M sh · $16.78M · Q3 2026
- Commodore Capital LP 2.93M sh · $14.20M · Q2 2026
- Almitas Capital LLC 1.47M sh · $7.11M · Q2 2026
- Boxer Capital Management, LLC 749.03K sh · $3.63M · Q2 2026
- Sio Capital Management, LLC 529.93K sh · $2.56M · Q2 2026
- Ally Bridge Group (NY) LLC 526.32K sh · $2.55M · Q2 2026
- Aldebaran Capital, LLC 367.71K sh · $1.96M · Q3 2026
- Prosight Management, LP 350.88K sh · $1.87M · Q3 2026
- Stonepine Capital Management, LLC 350.88K sh · $1.87M · Q3 2026
More on Spruce Street Capital LP
FAQ
How long has Spruce Street Capital LP held ANTX?
Spruce Street Capital LP has disclosed ANTX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Spruce Street Capital LP's current position in ANTX?
As of Q3 2026, Spruce Street Capital LP holds 1.75M shares of ANTX (AN2 THERAPEUTICS INC), valued at $9.32M, representing 1.48% of its reported portfolio and ranking #21.
Has Spruce Street Capital LP been buying or selling ANTX?
In the latest 13F filing (Q3 2026), Spruce Street Capital LP increased its position in ANTX. The position peaked in Q3 2026 at 1.75M shares.
Which other funds hold ANTX?
Other major institutional holders of ANTX include Vivo Capital, LLC, Commodore Capital LP, Almitas Capital LLC, among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.